Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.